UBS AM
CYRX icon

UBS AM’s CryoPort CYRX Stock Holding History

UBS AM’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Hold
908
– – ﹤0.01% 3203
2026
Q1 		$7.52K Buy
+908
New +$8.2K ﹤0.01% 3371
2024
Q4 		– Sell
-120,609
Closed -$978K – 2674
2024
Q3 		$978K Buy
120,609
+218
+0.2% +$1.78K ﹤0.01% 2407
2024
Q2 		$832K Buy
120,391
+67,501
+128% +$909K ﹤0.01% 2462
2024
Q1 		$936K Hold
52,890
– – ﹤0.01% 2043
2023
Q4 		$819K Hold
52,890
– – ﹤0.01% 2130
2023
Q3 		$725K Hold
52,890
– – ﹤0.01% 2134
2023
Q2 		$1.27M Hold
52,890
– – ﹤0.01% 1889
2023
Q1 		$1.27M Buy
52,890
+11,338
+27% +$247K ﹤0.01% 1889
2022
Q4 		$721K Buy
41,552
+5,359
+15% +$113K ﹤0.01% 2016
2022
Q3 		$882K Sell
36,193
-3,059
-8% -$105K ﹤0.01% 2037
2022
Q2 		$1.22M Sell
39,252
-5,321
-12% -$142K ﹤0.01% 1855
2022
Q1 		$1.56M Buy
44,573
+1,716
+4% +$64.9K ﹤0.01% 1927
2021
Q4 		$2.54M Buy
42,857
+792
+2% +$54.8K ﹤0.01% 1759
2021
Q3 		$2.8M Buy
42,065
+2,064
+5% +$127K ﹤0.01% 1679
2021
Q2 		$2.52M Buy
40,001
+6,428
+19% +$362K ﹤0.01% 1746
2021
Q1 		$1.75M Sell
33,573
-100
-0.3% -$6.08K ﹤0.01% 1813
2020
Q4 		$1.48M Buy
33,673
+4,400
+15% +$210K ﹤0.01% 1805
2020
Q3 		$1.39M Sell
29,273
-2,633
-8% -$107K ﹤0.01% 1703
2020
Q2 		$965K Buy
31,906
+606
+2% +$13.5K ﹤0.01% 1830
2020
Q1 		$534K Buy
31,300
+15,900
+103% +$278K ﹤0.01% 1955
2019
Q4 		$253K Buy
+15,400
New +$229K ﹤0.01% 2411

Other funds holding CYRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

UBS AM's CYRX Position: Q2 2026 in Review

UBS AM held its CryoPort (CYRX) position steady in Q2 2026 at 908 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3203.

UBS AM first reported a position in CYRX in Q4 2019 and has held it in 22 quarters since. The position peaked at $2.8M in Q3 2021. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • UBS AM held 908 shares of CryoPort worth $14.3K as of Q2 2026.
  • UBS AM left its CryoPort share count unchanged in Q2 2026.
  • CryoPort made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3203 holding.
  • UBS AM first reported a position in CryoPort in Q4 2019 and has held it in 22 quarters since.
  • UBS AM's CryoPort position peaked at $2.8M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.